Skip to content
healthcare.dev

Insulin glargine U-300 Max

NDC 0955-2900, insulin glargine, injection, solution, from Sanofi-Aventis U.S. LLC.

Product NDC
0955-2900
Status
Listed
Labeler
Sanofi-Aventis U.S. LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA206538
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0955-2900 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE300 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0955-2900-02009552900022 SYRINGE in 1 CARTON (0955-2900-02) / 3 mL in 1 SYRINGE (0955-2900-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/99ea856d-9562-443a-9422-1006a3cff2f4
  • NADAC price for package 00955290002

    GET /v1/drugs/nadac/00955290002

Use it

Look up 0955-2900 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0955-2900 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0955-2900. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.